kerecis

Kerecis partners with National Hospital of Iceland to evaluate effectiveness of Kerecis products on COVID-19 patients

Kerecis partners with National Hospital of Iceland to evaluate effectiveness of Kerecis products on COVID-19 patients

Kerecis and the National Hospital of Iceland are conducting a randomized, controlled, double-blind clinical study to evaluate the effectiveness of the Kerecis Omega3 Viruxide system on COVID-19 patients. The trial follows successful off-label use on Italian patients with COVID-19 symptoms. Omega3 Viruxide is a virucidal and bactericidal system used in
Michelle Spinei